Literature DB >> 17898789

Time-course-dependent microvascular alterations in a model of myeloid leukemia in vivo.

C Schaefer1, M Krause, I Fuhrhop, M Schroeder, P Algenstaedt, W Fiedler, W Rüther, N Hansen-Algenstaedt.   

Abstract

Functional and morphological properties of tumor microcirculation play a pivotal role in tumor progression, metastasis and inefficiency of tumor therapies. Despite enormous insights into tumor angiogenesis in solid tumors, little is known about the time-course-dependent properties of tumor vascularization in hematologic malignancies. The aim of this study was to establish a model of myeloid leukemia, which allows long-term monitoring of tumor progression and associated microcirculation. Red fluorescent protein-transduced human leukemic cell lines (M-07e) were implanted into cranial windows of severe combined immunodeficient mice. Intravital microscopy was performed over 55 days to measure functional (microvascular permeability, tissue perfusion rate and leukocyte-endothelium interactions) and morphological vascular parameters (vessel density, distribution and diameter). Tumor progression was associated with elevated microvascular permeability and an initial angiogenic wave followed by decreased vessel density combined with reduced tissue perfusion due to loss in small vessels and development of heterogenous tumor vascularization. Following altered geometric resistance of microcirculation, leukocyte-endothelium interactions were more frequent without increased leukocyte extravasation. It was concluded that time-dependent alterations of leukemic tumor vascularization exhibit strong similarities to those found in solid tumors. The potential contribution to the development of barriers to drug delivery in leukemic tumors is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898789     DOI: 10.1038/sj.leu.2404947

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

1.  Longitudinal Preclinical Imaging Characterizes Extracellular Drug Accumulation After Radiation Therapy in the Healthy and Leukemic Bone Marrow Vascular Microenvironment.

Authors:  Jamison Brooks; Darren Zuro; Joo Y Song; Srideshikan Sargur Madabushi; James F Sanchez; Chandan Guha; Marcin Kortylewski; Bihong T Chen; Kalpna Gupta; Guy Storme; Jerry Froelich; Susanta K Hui
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-11-09       Impact factor: 8.013

2.  Development of a preclinical PK/PD model to assess antitumor response of a sequential aflibercept and doxorubicin-dosing strategy in acute myeloid leukemia.

Authors:  Gerald J Fetterly; Urvi Aras; Deepika Lal; Michael Murphy; Patricia D Meholick; Eunice S Wang
Journal:  AAPS J       Date:  2013-04-03       Impact factor: 4.009

3.  Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.

Authors:  Juliana Benito; Marc S Ramirez; Niki Zacharias Millward; Juliana Velez; Karine G Harutyunyan; Hongbo Lu; Yue-Xi Shi; Polina Matre; Rodrigo Jacamo; Helen Ma; Sergej Konoplev; Teresa McQueen; Andrei Volgin; Marina Protopopova; Hong Mu; Jaehyuk Lee; Pratip K Bhattacharya; Joseph R Marszalek; R Eric Davis; James A Bankson; Jorge E Cortes; Charles P Hart; Michael Andreeff; Marina Konopleva
Journal:  Clin Cancer Res       Date:  2015-11-24       Impact factor: 12.531

Review 4.  Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence.

Authors:  Armin Rashidi; John F DiPersio
Journal:  Ther Adv Hematol       Date:  2016-02

5.  Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104.

Authors:  Juliana Benito; Yuexi Shi; Barbara Szymanska; Hernan Carol; Ingrid Boehm; Hongbo Lu; Sergej Konoplev; Wendy Fang; Patrick A Zweidler-McKay; Dario Campana; Gautam Borthakur; Carlos Bueso-Ramos; Elizabeth Shpall; Deborah A Thomas; Craig T Jordan; Hagop Kantarjian; William R Wilson; Richard Lock; Michael Andreeff; Marina Konopleva
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

6.  The bone microenvironment promotes tumor growth and tissue perfusion compared with striated muscle in a preclinical model of prostate cancer in vivo.

Authors:  Haider Mussawy; Lennart Viezens; Malte Schroeder; Svenja Hettenhausen; Jördis Sündermann; Jasmin Wellbrock; Kai Kossow; Christian Schaefer
Journal:  BMC Cancer       Date:  2018-10-16       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.